Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Sastasundar Ventures Limited ( (IN:SASTASUNDR) ) is now available.
Health X Platform Limited, formerly Sastasundar Ventures Limited, has a key operating arm in Sastasundar Healthbuddy Limited, its material subsidiary engaged in healthcare platform activities. Its shareholder base in the subsidiary includes strategic partner Rohto Pharmaceuticals and institutional investor Envision India Fund, underlining its positioning in technology-enabled healthcare services.
The board of HealthX has approved a Tripartite Agreement with Sastasundar Healthbuddy Limited and Envision India Fund, following Envision’s deal to acquire Mitsubishi Corporation’s entire shareholding in the subsidiary. The agreement envisages a future merger of the subsidiary into HealthX, or alternatively a share swap, to preserve Envision’s economic interest and gives Envision rights to board representation, signaling a move toward tighter group integration, capital restructuring and enhanced institutional influence in the company’s governance.
More about Sastasundar Ventures Limited
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, operates in the digital health and pharmacy space through its material subsidiary Sastasundar Healthbuddy Limited. The group focuses on healthcare platforms and related services, supported by strategic investors such as Rohto Pharmaceuticals and institutional investors, reflecting a technology-driven healthcare market orientation.
Average Trading Volume: 459
Technical Sentiment Signal: Sell
Current Market Cap: 8.89B INR
For a thorough assessment of SASTASUNDR stock, go to TipRanks’ Stock Analysis page.